About YenZym
YenZym is a Healthcare company based in San Francisco (United States) founded in 2006. It provides custom antigen design and antibody production for researchers worldwide. It operates on a B2B model. YenZym offers products and services including Antigen Design Service, Rabbit Antibody Service, Anti-PTM Antibody Service, Customized Antibody Regimen, and Chicken Antibody Service. Its focus areas include Life Sciences, Immunology, Protein Analysis and Custom Production. Its legal entity is YenZym Antibodies, LLC. Its competitors include GenScript, Epitomics and Vector Laboratories; 2 of its 3 listed competitors have raised funding.
Company details
YenZym Antibodies specializes in custom antibody services, including antigen design and production for proteins like GPCRs and post-translationally modified ones. Led by experienced scientists, they use tailored immunization regimens and affinity purification to assist investigators. Based in Brisbane, California, USA, they serve research needs with options like rabbit and chicken antibodies, ensuring high-quality results for scientific applications.
- Headquarters San Francisco, United States
- SectorsHealthcare
- Email••••••••
- Website yenzym.com
- Legal Name Yenzym Antibodies, Llc
Products & Services of YenZym
YenZym offers a comprehensive portfolio of products and services, including Antigen Design Service, Rabbit Antibody Service, Anti-PTM Antibody Service, Customized Antibody Regimen, and Chicken Antibody Service.
Service for designing antigens to produce effective antibodies
Production of polyclonal antibodies using rabbits for research
Antibodies targeting post-translational modifications like phosphorylations
Regimen for high-affinity antibodies against low-expression proteins
Production of antibodies using chickens for specific applications
Competitors of YenZym
YenZym has 3 listed competitors in our database, 2 of them funded. They include GenScript, Epitomics and Vector Laboratories.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| epitomics.com | 2001 | Burlingame, United States | $16.21M | Monoclonal antibody technology and products are developed by Epitomics. | ||
| vectorlabs.com | 1976 | Burlingame, United States | Labeling and detection reagents immunohistochemistry studies and other life science research applications |
Detailed competitors of YenZym
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of YenZym
Websites that share an audience with YenZym (yenzym.com).
Websites whose visitors overlap most with YenZym. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| immunomedics.com | 100% | View details | |||
| medarex.com | 96% | View details | |||
| qedbio.com | 92% | 4.9K | #3,910,628 | View details | |
| agrisera.com | 82% | 29.3K | #933,013 | View details | |
| epitomics.com | 80% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for YenZym
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Immunology & Cancer Therapeutics
3 companies that operate in the same segment as YenZym (Immunology & Cancer Therapeutics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | |||
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about YenZym
YenZym was founded in 2006.
YenZym is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
YenZym Antibodies specializes in custom antibody services, including antigen design and production for proteins like GPCRs and post-translationally modified ones. Led by experienced scientists, they use tailored immunization regimens and affinity purification to assist investigators. Based in Brisbane, California, USA, they serve research needs with options like rabbit and chicken antibodies, ensuring high-quality results for scientific applications.
YenZym's top competitors include GenScript, Epitomics and Vector Laboratories.
YenZym offers Antigen Design Service, Rabbit Antibody Service, Anti-PTM Antibody Service, Customized Antibody Regimen, and Chicken Antibody Service.
YenZym operates through Yenzym Antibodies, Llc.